
Introducing the Needs Assessment Tool : Interstitial Lung Disease
Are you a clinician or service manager working with people with Interstitial Lung Disease? You are invited to attend this exciting event, which presents the NAT:ILD, an
Stay connected and stay informed. Explore our news articles on all things ILD.

Are you a clinician or service manager working with people with Interstitial Lung Disease? You are invited to attend this exciting event, which presents the NAT:ILD, an

Twitter Chat: Wednesday 21st September: 8 pm The British Lung Foundation is marking IPF Week with a number of activities, including a Twitter Chat for

“Fit for the Future: Future-proofing care for patients with IPF” On 12th July 2016 Action for Pulmonary Fibrosis met members of the All-Party Parliamentary Respiratory

From its conception the ILD-INN has aimed to become truly interdisciplinary. To this end we are pleased to welcome new committee members Catherine Dixon Respiratory

Best Wishes for your retirement from the ILD-INN At our last committee meeting Heather informed us that she was retiring from her NHS post and

The first issue of the BTS ILD Registry Newsletter has been published, providing information on current developments and highlighting Registry findings regarding lung function and

The South West Interstitial Lung Disease Interdisciplinary Network have announced their latest event “Managing Patients with Interstitial Lung Disease”. Click here for more details

This month saw the first meeting of the Welsh ILD-INN at Miskin Manor. The meeting was attended by nurses and allied health professionals from health

We are pleased to inform you that we have now developed a regional networks page on the website. The ILD-INN is keen to support the

This website regularly posts updates of research by Boehringer Ingelheim. It is not exclusive to ILD updates include other respiratory areas of interest such as

In February we posted a news article informing members that the European IPF Charter had been published. Bruno Crestani published an interesting article in the

The long awaited guidance on the use of Nintedanib to treat IPF has been published by NICE. Nintedanib for treating idiopathic pulmonary fibrosis NICE technology
